279 related articles for article (PubMed ID: 38511067)
1. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.
Xu D; Wang W; Wang D; Ding J; Zhou Y; Zhang W
Noncoding RNA Res; 2024 Jun; 9(2):388-406. PubMed ID: 38511067
[TBL] [Abstract][Full Text] [Related]
2. MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.
Hussein MA; Valinezhad K; Adel E; Munirathinam G
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201661
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Networks of LncRNA MALAT-1 in Cancer.
Fu S; Wang Y; Li H; Chen L; Liu Q
Cancer Manag Res; 2020; 12():10181-10198. PubMed ID: 33116873
[TBL] [Abstract][Full Text] [Related]
4. The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O; Moalemnia A; Ghaedrahmati F; Shooshtari MK; Khoshnam SE; Kempisty B; Halili SA; Farzaneh M; Morenikeji OB
BMC Nephrol; 2023 Dec; 24(1):380. PubMed ID: 38124072
[TBL] [Abstract][Full Text] [Related]
5. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma.
Atwa SM; Handoussa H; Hosny KM; Odenthal M; El Tayebi HM
World J Hepatol; 2020 Dec; 12(12):1211-1227. PubMed ID: 33442449
[TBL] [Abstract][Full Text] [Related]
7. Malat1 regulates PMN-MDSC expansion and immunosuppression through p-STAT3 ubiquitination in sepsis.
Wang Y; Zhang C; Liu T; Yu Z; Wang K; Ying J; Wang Y; Zhu T; Li J; Hu XL; Zhou Y; Lu G
Int J Biol Sci; 2024; 20(4):1529-1546. PubMed ID: 38385073
[TBL] [Abstract][Full Text] [Related]
8. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
Yadav A; Biswas T; Praveen A; Ganguly P; Bhattacharyya A; Verma A; Datta D; Ateeq B
Cancer Res Commun; 2023 Oct; 3(10):2044-2061. PubMed ID: 37812088
[TBL] [Abstract][Full Text] [Related]
9. MALAT1 regulates network of microRNA-15a/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma.
Yan H; Gao S; Xu A; Zuo L; Zhang J; Zhao Y; Cheng Q; Yin X; Sun C; Hu Y
Carcinogenesis; 2023 Dec; 44(10-11):760-772. PubMed ID: 37549238
[TBL] [Abstract][Full Text] [Related]
10. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M
Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966
[TBL] [Abstract][Full Text] [Related]
11. Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.
Taheri M; Badrlou E; Hussen BM; Kashi AH; Ghafouri-Fard S; Baniahmad A
Front Oncol; 2023; 13():1123101. PubMed ID: 37025585
[TBL] [Abstract][Full Text] [Related]
12. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
13. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK.
Choi S; Ismail A; Pappas-Gogos G; Boussios S
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839570
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
